Company

Share

分配年度 分配預案的股本基數(股) 分配方案(每10股) 現金分紅總額(元)(含稅) 股權登記日 除權/除息日 分紅派息日 送紅股(... 【More>>】

優得清角膜

分配年度 分配預案的股本基數(股) 分配方案(每10股) 現金分紅總額(元)(含稅) 股權登記日 除權/除息日 分紅派息日 送紅股(股) 轉增股(股) ... 【More>>】

左6

Grandhope Biotech successfully listed on Shenzhen GEM

July 6, 2011, Grandhope Biotech successfully listed on Shenzhen GEM (growth enterprise market), with the stock code 300238. The share circulation of this time is 1,530 million, with the price of 18.20 RMB per share and the P/E ratio of 38.16. The money raised from the shares is mainly used for the construction of the“National Engineering Laborator... 【More>>】

Postdoctoral Programme

Recently, the ministry of human resources and social security and the committee of national postdoctoral management have released the notice that 489 enterprises were authorized to establish postdoctoral research station. Grandhope Biotech was successfully listed. The application of the postdoctoral research station needs to pass a strict... 【More>>】

Deloitte Technology Fast 50 China and 500 Asia Pacific 2010

On Dec. 2 2010, the award ceremony of "Deloitte Technology Fast 50 China and 500 Asia Pacific" is held in Hong Kong. In this selection, 147 enterprises of mainland China have been on list, which become the most of the Asia Pacific region. With the rapid growth of the last three years, Grandhope Biotech has again been on the list since th... 【More>>】

Sitemap

關于冠昊 企業概況 企業文化 生產基地 管理團隊 發展戰略 領導關懷 企業榮譽 公司大事記 科技研發 冠昊技術 冠昊材料 資質證書 產品介紹 產品特點 上市產品 在研產品 再生醫學工程研究院 國家工程實驗室 新聞資訊 最新熱點 公司動態 媒體報道 營銷網絡 國內網絡 國際網絡 投資者關系 人才招聘 用人之道 薪酬福利 職業發展 招聘流程 招聘信息 聯系... 【More>>】

2014年度股東大會決議公告(en)

Sitemap

關于冠昊 公司概況 企業文化 發展歷程 企業榮譽 核心團隊 領導關懷 分子公司 聯系我們 新聞中心 公司動態 行業資訊 視頻中心 產業布局 再生材料領域 細胞領域 干細胞領域 孵化創投 服務支持 營銷網絡 售后服務 國家工程實驗室 國家工程實驗室 組織架構 研發團隊 研發項目 投資者關系 股市行情 互動平臺 定期報告 臨時公告 法人治理 新聞資訊 投資者關系管理 用人之道 人才培育 招賢納士 冠... 【More>>】

2015年3月11日投資者關系活動報告(en)

《公司章程》(2015年2月)(en)

干細胞與轉化醫學重點專項實施方案征求意見(en)

干細胞與轉化醫學重點專項實施方案征求意見 (en) 鏈接地址:http://www.most.gov.cn/tztg/201502/t20150226_118286.htm 日期:2015年02月26日 來源:科技部 根據國務院《關于深化中央財政科技計劃(專項、基金等)管理改革的方案》總體要求,科技部將會同有關部門,啟動國家重點研發計劃“干細胞與轉化醫學”重點專項試點工作... 【More>>】

2014年年度報告摘要(en)

醫療器械分類規則(修訂草案) (征求意見稿)(en)

境內醫療器械注冊質量管理體系核查操作規范(en)

《醫療器械標準管理辦法》(en)

大動脈覆膜支架系統的臨床試驗指導原則(en)

《醫療器械經營監督管理辦法》(局令第8號)(en)

《醫療器械生產監督管理辦法》(局令第7號)(en)

2011 Forbes China Up & Comers

Recently, the Forbes China has released the list of 2011 Forbes China Up and Comers. 200 enterprises were on the list. With the rapid and stable development, Grandhope Biotech has been successfully selected again, ranking 57th this year. It’s the seventh time that Forbes has such a comprehensive and independent investigation during Chinese small and medium-sized enterprises, whic... 【More>>】

2011 Forbes China Up & Comers

Recently, the Forbes China has released the list of 2011 Forbes China Up and Comers. 200 enterprises were on the list. With the rapid and stable development, Grandhope Biotech has been successfully selected again, ranking 57th this year. It’s the seventh time that Forbes has such a comprehensive and independent investigation during Chinese small and medium-sized enterprises, whic... 【More>>】

NormalGEN ? dura repair patch

Biomaterials Field

Technologies We have established a series of proprietary technologies, turning animal tissues into regenerative medical materials, and overcoming traditional methods of having permanent foreign materials inside the body. 1.Tissue Fixation: using innovative epoxy crosslinking technique, we are able to fix the tissue at a pre-determined bio-stability. The degradation rate is synchronized w... 【More>>】

Biomaterials Field

Materials Key advantages of Guanhao Materials: 1.Similar composition and structure to that of the replaced tissues. 2.Superior biocompatibility to host tissues. 3.Excellent mechanical properties such as compliance and strength. 4.Synchronized degradation rates with host tissue regeneration. 5.Promotes host tissue and organ regeneration. The regenerative medical materia... 【More>>】

Guanhao-ACI

Guanhao-ACI Human autologous chondrocyte implantation (ACI) is used for the repair and the regeneration of cartilage defects. The autologous chondrocytes from the patient are expanded in vitro, seeded on a collagen membrane to form human tissue engineered cartilage and then implanted to the cartilage defect to promote the regeneration of cartilage tissue. The ACI technique has been used in m... 【More>>】

Immune cell bank Everyone has its own immune cells to protect the health. The mechanism of immune cell therapy is to use people’s own immune cells to fight against diseases, namely using cells expanded in vitro to enhance the ability of people to fight against pathogens. A key factor of immune cell therapy is the good T cells. When people are getting old, immune cells will degenerate. A... 【More>>】

BEIHAO STEM CELL AND REGENERATIVE MEDICINE RESEARCH INSTITUTE

Stem cells are a group of multipotent cells with the self-renewal ability. In certain conditions, they can differentiate into many functional cells, which have the potential to regenerate tissues and organs and even the human body. Stem cell technologies, or regenerative medicine technologies, are the most prosperous and fast developing in the biotechnology field. Stem cell and regenerati... 【More>>】

Adhering to the market-oriented business philosophy,Guanhao Biotech has established a well-trained sales team and distribution network covering the whole China. In 2008, our Shanghai branch has been set up as a marketing center for the company, responsible for sales of Guanhao products in both domestic and overseas market. Soon afterwards, more branch companies have been set up in B... 【More>>】

Constructing 【More>>】

2008-09 Chairman Xi Jinping of China visited

2008年12月,國家主席習近平聽取徐斌總經理匯報 【More>>】

zhang

1997

1997 Nov. 1997 AV Healing founded in California, USA.. 【More>>】

Corporate Culture We know, An excellent enterprise, is to create a can make all the staff in unision core values and sense of mission, a can promote staff and progressive work environment, one can ensure that enterprises operating performance and constantly improve the system arrangement to actively promote the organizational change and deve... 【More>>】

About Us

About Us Guanhao Biotech develops, manufactures and markets life and health related products, with focus on regenerative medicine. We strive to be a world-renowned pioneer in the field of life and health, under the mission “technology transforms into health”. We have a strong research and development team, holding over 20 grants and funds from cen... 【More>>】

Grandhope Biotech successfully listed on Shenzhen GEM

July 6, 2011, Grandhope Biotech successfully listed on Shenzhen GEM (growth enterprise market), with the stock code 300238. The share circulation of this time is 1,530 million, with the price of 18.20 RMB per share and the P/E ratio of 38.16. The money raised from the shares is mainly used for the construction of the“National Engineering Laboratory for Regenerative Implantable Me... 【More>>】